Kevin Johnson of Medicxi Ventures, had this to say…
“It was a pleasure to work with Confluence Tax on the Capella Series A investment. I would not hesitate to recommend them to anyone wishing to understand and negotiate the tax and structuring issues of biotech”.
http://www.capellabioscience.com/news/
_______________________________________________